Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
on air now
Advertisement
Advertisement
Advertisement

Amplia Therapeutics: An oral cancer drug trial with serious results!

Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein. 

 

BULLS N' BEARS
Advertisement